By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Multikinase inhibitors > Balversa
Multikinase inhibitors

Balversa

https://themeditary.com/drug/balversa-985.html
Medically Reviewed by Judith Stewart, BPharm TheMediTary.Com | Reviewed: Jul 12, 2023  Additional Content by TheMediTary.Com

Generic name: erdafitinib [ er-da-fi-ti-nib ]

Drug class: Multikinase inhibitors

Dosage form: tablet, film coated

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Erdafitinib

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Balversa?

Balversa is used in adults to treat bladder cancer that has spread to other parts of the body (metastatic), or cannot be removed with surgery.

Balversa is used only if your cancer has a specific genetic marker (an abnormal "FGFR" gene), and if you were treated with at least one other platinum cancer medicine that did not work or has stopped working. Your doctor will test you for this gene.

Balversa is usually given after other treatments have failed.

Balversa was approved by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, some people responded to this medicine, but further studies are needed.

Warnings

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

Before taking this medicine

It may be harder for you to get pregnant while you are using Balversa. You should still use birth control to prevent pregnancy because the medicine can harm an unborn baby.

You may need to have a negative pregnancy test before starting Balversa.

Tell your doctor if you have ever had problems with your eyes or vision.

Both men and women using this medicine should use effective birth control to prevent pregnancy. Erdafitinib can harm an unborn baby or cause birth defects if the mother or father is using this medicine.

Keep using birth control for at least 1 month after your last dose. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using Balversa.

Do not breastfeed while using this medicine, and for at least 1 month after your last dose.

Balversa pregnancy and breastfeeding warnings (more detail)

How should I take Balversa

Take Balversa exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose.

Swallow the Balversa tablets whole, once daily, with or without food. The recommended initial dosage is 8 mg once daily with a dose increase to 9 mg daily if certain criteria are met.

If you vomit shortly after taking Balversa, do not take another dose. Wait until your next scheduled dose time to take the medicine again.

Your doctor may want you to use artificial tears or other lubricating eye medication every 2 hours while you are awake. Keep using these medicines for as long as your doctor has prescribed.

Your blood will need to be tested often. Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

You will need frequent vision tests.

Store at room temperature away from moisture and heat.

Dosing information

Usual Adult Dose for Urothelial Carcinoma:

8 mg orally once daily; increase to 9 mg orally once daily based on serum phosphate levels and tolerability at 14 to 21 days until disease progression or unacceptable toxicity

Comments
-Select patients for therapy based on the presence of susceptible FGFR genetic alterations in tumor specimens as detected by an FDA-approved companion diagnostic.

Use: For the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC), that has susceptible FGFR3 or FGFR2 genetic alterations, and progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.

Detailed Balversa dosage information
Balversa Dosage information (more detail)

Before Taking

It may be harder for you to get pregnant while you are using Balversa. You should still use birth control to prevent pregnancy because the medicine can harm an unborn baby.

You may need to have a negative pregnancy test before starting Balversa.

Tell your doctor if you have ever had problems with your eyes or vision.

Both men and women using this medicine should use effective birth control to prevent pregnancy. Erdafitinib can harm an unborn baby or cause birth defects if the mother or father is using this medicine.

Keep using birth control for at least 1 month after your last dose. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using Balversa.

Do not breastfeed while using this medicine, and for at least 1 month after your last dose.

Balversa pregnancy and breastfeeding warnings (more detail)

Related/similar drugs

Keytruda, pembrolizumab, cisplatin, nivolumab, doxorubicin, Opdivo, Trodelvy

What happens if I miss a dose?

Take the missed dose on the same day you remember it. Take your next dose at the regular time the next day. Do not use two doses in one day.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Balversa?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Balversa side effects

Get emergency medical help if you have signs of an allergic reaction to Balversa: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

You may have high phosphate levels, and your blood will need to be tested often. Tell your doctor if you have symptoms such as numbness or tingling around your mouth, muscle stiffness, body aches, itching or rash, tiredness, trouble sleeping, nausea, vomiting, loss of appetite, or feeling short of breath.

Call your doctor at once if you have:

  • vision problems, vision loss;

  • eye pain or redness; or

  • problems with your fingernails or toenails - pain, bleeding, separation of the nails from the skin (nail bed), unusual breakage, changes in nail color or texture, cracks or infection in your cuticles.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common Balversa side effects may include:

  • dry eyes;

  • dry mouth, mouth sores;

  • hair loss;

  • dry skin, problems with your fingernails or toenails;

  • redness, swelling, pain, or blisters on the palms of your hands or the soles of your feet;

  • muscle pain;

  • feeling tired;

  • abnormal liver or kidney function tests;

  • low sodium levels, low red blood cell count;

  • nausea, stomach pain, loss of appetite;

  • diarrhea, constipation; or

  • changes in your sense of taste.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Balversa Side Effects

What other drugs will affect Balversa?

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Tell your doctor about all your other medicines, especially:

  • medicines that may change phosphate levels - potassium phosphate supplements, vitamin D supplements, antacids, enemas or laxatives that contain phosphate, and other medicines known to contain phosphate.

Other drugs may interact with erdafitinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

More about Balversa (Erdafitinib [ er-da-fi-ti-nib ])

Dosage information
Balversa Side Effects
During pregnancy
Balversa Prescribing Information
Drug images
Side effects
Drug class: Multikinase inhibitors

Related treatment guides

Urothelial Carcinoma
Bladder Cancer
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by